2019•Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of LipidsRequires access

Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH

Adriana Carino, Michele Biagioli, Silvia Marchianò, Chiara Fiorucci, Angela Zampella, Maria Chiara Monti, Paolo Scarpelli, Patrizia Ricci, Eleonora Distrutti, Stefano Fiorucci

Open publisher page 72 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 72 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Farnesoid X receptor, Ursodeoxycholic acid, Obeticholic acid, Internal medicine, Bile acid, Endocrinology, Steatosis, Fatty liver